Drugs / HB-MSC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03994666 | Sep 2019 → Dec 2020 | limb ischemia | Reims University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HB-MSC1 | “Study drug and dosage form : Umbilical cord-derived mesenchymal stem cells (HB-MSC1)” NCT03994666 ↗ |
| Known as | Umbilical cord-derived mesenchymal stem cells | “Study drug and dosage form : Umbilical cord-derived mesenchymal stem cells (HB-MSC1)” NCT03994666 ↗ |
| Modality | Cell therapy | “Umbilical cord-derived mesenchymal stem cells (HB-MSC1)” NCT03994666 ↗ |